期刊文献+

血糖与良性前列腺增生症的相关性分析

Correlation analysis of blood glucose and benign prostatic hyperplasia
下载PDF
导出
摘要 目的:分析前列腺增生的影响因素,重点探讨与血糖的相关性。方法:回顾性分析1 500例患者的临床资料,检测其相关指标,研究前列腺体积与各指标的相关性,分析影响良性前列腺增生症病情进展的相关因素。结果:前列腺体积与年龄、体重指数、收缩压、血糖水平存在显著的正相关(P<0.05);良性前列腺增生患者BMI、FBG、HBA1C水平均较非良性前列腺增生患者显著升高(P<0.05)。结论:年龄、体重指数、收缩压、血糖水平是前列腺体积变化的重要反映,而BMI、FBG、HBA1C是前列腺增生患者病情发展的重要危险因素。 Objective:To analyze the influence factors of prostatic hyperplasia,to discuss mainly the relationship between the blood glucose.Methods:The clinical data of 1500 patients were retrospectively analyzed.The relevant indexes were detected.The correlation between prostate volume and the indexes was studied.The factors affecting the progress disease of benign prostatic hyperplasia were analyzed.Results:The prostate volume had significantly positively correlated with age,body mass index,systolic blood pressure and blood glucose level(P<0.05).The BMI,FBG and HBA1 C level of patients with benign prostatic hyperplasia were significantly higher than those of patients with no benign prostatic hyperplasia(P<0.05).Conclusion:The age,body mass index,systolic blood pressure and blood glucose level are the important factors of prostate volume change,and BMI,FBG and HBA1 C are the important risk factors of the progress disease of patients with benign prostatic hyperplasia.
作者 王冰 王哲
出处 《中国社区医师》 2015年第33期115-116,共2页 Chinese Community Doctors
关键词 良性前列腺增生症 影响因素 相关分析 Benign prostatic hyperplasia Influence factor Correlation analysis
  • 相关文献

参考文献3

二级参考文献33

  • 1张振香.国际糖尿病联盟和中华医学会糖尿病学会代谢综合征诊断标准比较[J].郑州大学学报(医学版),2007,42(2):337-339. 被引量:16
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 3Kasturi S, Russell S, Mcvary KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curt Urol Rep, 2006, 7(4): 288-292.
  • 4Dahle SE, Chokkalingam AP, Gao YT, et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol, 2002, 168(2): 599-604.
  • 5Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol, 2001, 39(2): 151158.
  • 6张祥华,主编.中国良性前列腺增生诊断治疗指南2007版.人民卫生出版社,2007:167-205.
  • 7Ozden C, Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol, 2007, 51(1): 199-206.
  • 8Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia, l Clin Endocrinol Metab, 2006, 91 (7): 2562-2568.
  • 9Gupta A, Gupta S, Pavuk M, et al. Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of air force veterans. Urology, 2006, 68(6): 1198-1205.
  • 10Park HK, Lee HW, Lee KS, et al. Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population. Urology, 2008, 72(3): 556-560.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部